Cooper Companies stock

COO · NASDAQ · USD

Compare Cooper Companies
$62.65Change from previous close: +0.74%Absolute change: +$0.46

Close · November 13, 2026

Price history

−12.68% over the period

1 year: from $71.75 (November 13, 2025) to $62.65 (November 13, 2026), −12.68%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 13, 2026$62.65
October 30, 2026$59.55
September 30, 2026$56.53
August 31, 2026$70.09
July 31, 2026$72.32
June 30, 2026$71.71
May 29, 2026$61.21
April 30, 2026$62.90
March 31, 2026$71.50
February 27, 2026$83.67
January 30, 2026$81.38
December 31, 2025$81.96
November 28, 2025$77.93
November 13, 2025$71.75

At a glance

  • The company

    Develops and markets contact lenses, and provides family and women's health care products including fertility solutions and contraceptive devices

  • Latest results

    Quarter to July 31, 2026 · EPS $1.15 (estimate $1.12)

TickerLandia's take on Cooper Companies

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$51.01
52-wk high$89.83

−30.26% from the 52-week high

Analysts · 17 analysts

Average target$65.80+5.03% vs. price

Buy 5 · Hold 12 · Sell 0 · Hold

TickerLandia Fingerprint: Cooper Companies

Compared with similar companies: low price, weak momentum, and high earnings stability.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Cooper Companies is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Cooper Companies's P/E today is 33.5, below the median of its last 4 fiscal years (45.0; between 35.2 and 53.4 from 2022 to 2025). Cooper Companies's P/E (trailing 12 months): 21.5, −37% against the median of a group of 9 similar companies (34.2).

P/E compared with its history

Compared with 9 similar companies

Cooper Companies's metrics compared with similar companies
MetricCooper CompaniesPosition in the groupBand
P/E (trailing 12 months)21.5Low
Forward P/E13.4Low
Operating margin12.9%Middle
ROE6.8%Middle
Debt/equity0.34Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Cooper Companies. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$1.07B

Latest quarter · Q to Jul 2026

Net income

$432.8M

Latest quarter · Q to Jul 2026

Quarterly net margin

40.6%

Latest quarter · Q to Jul 2026

Numbers and valuation

Full valuation
Market cap
$11.91B
P/E
21.5
EPS
$2.91
Volume
1.57M
Daily trading
€143.13M

How Cooper Companies is changing

All results
  • Revenue grew 11.0% a year on average over the last 5 years

  • Operating margin rose from 15.3% to 16.7%

  • Free cash flow equal to 88% of net income

Returns

Cooper Companies returns with dividends

$1,000 invested in Cooper Companies 5 years ago, on November 15, 2021, would be worth $602 today with dividends reinvested: −39.80% in total, −9.66% per year. On price alone it would be $602 (−39.82%).

PeriodCooper CompaniesS&P 500$1,000 becomes
1 month+14.76%−3.12%$1,148
6 months+5.35%+1.58%$1,053
Year to date−23.56%+10.46%$764
1 year−12.68%+12.23%$873
3 years−24.19%+71.41%$758
5 years−39.80%+61.48%$602
10 years+47.51%+249.40%$1,475

Over the last 6 months it has done better than 32% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Cooper Companies: technical analysis

Cooper Companies shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 45.0% below its highest close since January 2, 1990 ($113.98, September 3, 2021).

Trend
No clear trend
RSI (14 sessions)
57
Between 30 and 70
vs 200-session average
−7.82%

Support and resistance

Price areas where Cooper Companies has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$72.59+15.87%2 touches, last on April 14, 2026
  2. Resistance$68.69+9.64%3 touches, last on July 14, 2026
  3. Resistance$65.24+4.13%2 touches, last on November 5, 2026
  4. Last price$62.65
  5. Support$59.01−5.80%2 touches, last on June 2, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.48
Volatility (60 sessions, annualised)
45.8%
Largest fall in the last year
−36.82%

Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Cooper Companies: seasonality

Average monthly price change over 37 years

+2.9%Jan+0.4%Feb+5.0%Mar−0.2%Apr+2.5%May−0.1%Jun+2.9%Jul+2.4%Aug+2.1%Sep−2.6%Oct+0.5%Nov+2.6%Dec

Over the last 37 years, the strongest month for Cooper Companies has been March: +4.98% on average, positive in 27 years out of 37. The weakest has been October: −2.57% on average, positive in 20 years out of 37. November, the current month, has been positive in 20 years out of 36 (+0.51% on average).

Show chart data
MonthAverageMedianPositive years
January+2.94%+2.53%24 of 36
February+0.40%+2.69%22 of 37
March+4.98%+3.56%27 of 37
April−0.17%+0.03%19 of 37
May+2.51%+2.08%20 of 37
June−0.07%0.00%18 of 37
July+2.92%+0.15%19 of 37
August+2.40%+1.34%19 of 37
September+2.14%+0.96%19 of 37
October−2.57%+0.95%20 of 37
November+0.51%+1.37%20 of 36
December+2.63%+2.93%20 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Cooper Companies and its competitors

CooperVision, the contact lens segment, makes spherical, toric and multifocal lenses that correct astigmatism, presbyopia and myopia. The second segment, CooperSurgical, serves women's healthcare with fertility consumables and equipment, contraceptive devices, the hormone-free Paragard intrauterine device, and storage of umbilical cord material. Its products reach distributors, group purchasing bodies, eye care clinicians, hospitals, clinics and authorized resellers across several regions.

Headquarters
San Ramon, United States
Employees
15,000
Founded
1980
Chief executive
Albert White
Cooper Companies and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Cooper CompaniesCOO$11.91B12.9%21.5+5.35%
Align TechnologyALGN$11.86B19.6%24.5+4.06%
Baxter InternationalBAX$13.35B7.6%—+49.10%
AvantorAVTR$10.53B8.0%31.1+97.46%
RepligenRGEN$10.73B8.1%—+56.77%
SolventumSOLV$15.14B5.9%100.1+19.72%

Same industry or related industries, similar size. Compare Cooper Companies with its competitors · Full profile